DVAX
Dynavax Technologies Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$15.50
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.40x
- Price / sales
- 5.50x
- Price / cash flow
- 20.06x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 4.40x
- EV / EBITDA
- -56.75x
- EV / EBIT
- 139.44x
- Market cap
- $1.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2025